Why Pacira Biosciences Stock Sank Today

Why Pacira Biosciences Stock Sank Today

Submitted by admin on October 4, 2021 - 11:04pm
Source: 
Motley Fool
News Tags: 
Pacira
eVenus
FDA
generics
EXPAREL
non-opioid pain treatments
Headline: 
Why Pacira Biosciences Stock Sank Today
snippet: 
  • eVenus Pharmaceutical Laboratories has filed for FDA approval of a generic version of Pacira's Exparel.
  • The non-opioid pain drug generated nearly all of Pacira's revenue in the second quarter.
  • Pacira plans to "vigorously defend its intellectual property rights."

Do Not Allow Advertisers to Use My Personal information